About 40 Trademarks found that are owned by Regenxbio Inc.

Custom manufacture of reagents for scientific and medical research and development; Custom manufacturing services, namely, production for others of clinical and medical reagents for use in gene therapy, for development of pharmaceutical preparations for use in gene therapy, and of therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)

Custom design and development of reagents for scientific and medical research and development

Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy

Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others

The mark consists of the words "AFFINITY BEYOND" below different sizes circles at the left side corner. The letter "A" of the word "AFFINITY" is written in stylized font. The letter "E" of the word "BEYOND" is written in a stylized font.

The mark consists of the words "AFFINITY BEYOND" below different sizes circles at the left side corner shaded from lighter to darker orange. The word "AFFINITY" is written in navy blue color having the letter "A" written in a stylized font. The word "BEYOND" is written in the color navy blue except the letter "O" written in sky blue color. The letter "E" of the word "BEYOND" is written in a stylized font.

Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others

The mark consists of a sequence of dots with the words "AFFINITY DUCHENNE" written to the right side. The A in the word "AFFINITY" is written in a stylized font.

Biotechnological platform technology, namely, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)

Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others

The mark consists of a cluster of circles of varying size which create a larger circle. The cluster of circles surround a circle with a triangular shape inside. The wording "REGENXBIO" in stylized form appears to right of the cluster of circles.